MH vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

MH

64.7
AI Score
VS
MH Wins

UTI

46.4
AI Score

Investment Advisor Scores

MH

65score
Recommendation
BUY

UTI

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MH UTI Winner
Forward P/E 17.452 29.2398 MH
PEG Ratio 0 1.9511 Tie
Revenue Growth -5.5% 7.2% UTI
Earnings Growth -20.9% -78.9% MH
Tradestie Score 64.7/100 46.4/100 MH
Profit Margin 3.5% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD MH

Relative Price Performance (Last 90 Days)

MH 1M: -16.6% · 3M: -15.6% UTI 1M: +10.8% · 3M: -10.5%

Current Technical Phase

MH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.9 · Price: $11.06

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.7 · Price: $22.51

Fundamentals Snapshot

Metric MH UTI
Market Cap — —
Forward P/E 6.2 31.3
Trailing P/E 29.9 38.0
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.8% 0.6%
Operating Margin 0.2% 0.0%
EPS 0.36 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.